Literature DB >> 4300184

Individualities of vascular smooth muscles in response to angiotensin.

D F Bohr, E Uchida.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 4300184

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  8 in total

1.  [Effect of angiotensin II on an autorhythmic vascular smooth muscle (portal vein of the rat)].

Authors:  D Voth; M Agsten; R Schipp; H Lübcke
Journal:  Arch Kreislaufforsch       Date:  1971 May-Jun

2.  Motor innervation of the coronary arteries of the cat.

Authors:  A M Brown
Journal:  J Physiol       Date:  1968-09       Impact factor: 5.182

3.  Effect of angiotensin on vascular smooth muscles.

Authors:  P Walter; E Bassenge
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

4.  Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein.

Authors:  J S Zhang; J C Van Meel; M Pfaffendorf; P A Van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

5.  Mechanism of action of angiotensin II on excitation-contraction coupling in the rat portal vein.

Authors:  G Hamon; M Worcel
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

Review 6.  Role of the adrenal cortex and sodium in the pathogenesis of human hypertension.

Authors:  J Genest; W Nowaczynski; R Boucher; O Kuchel
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262

7.  Long-term effects of brief antihypertensive treatment on systolic blood pressure and vascular reactivity in young genetically hypertensive rats.

Authors:  O Traub; M C Lloyd; R C Webb
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

8.  Angiotensin II causes endothelial-dependent increase in expression of Ca(V)1.2 protein in cultured arteries.

Authors:  Wen-Ze Wang; Li Pang; Philip Palade
Journal:  Eur J Pharmacol       Date:  2008-09-30       Impact factor: 4.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.